ESPR Esperion Therapeutics, Inc.

Fundamentals / CIK 0001434868 / USD

Esperion Therapeutics, Inc. reported $418.2M in revenue and a net loss of $7.42M for the trailing twelve months ended March 31, 2026 (up 23.2% year over year), with a 18.1% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ESPR in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$425.7M$212.9M$0-$285.9MFY 2016 Net Income: -$74.98M2016FY 2017 Net Income: -$167.0M2017FY 2018 Revenue: $0FY 2018 Net Income: -$201.8M2018FY 2019 Revenue: $148.4MFY 2019 Net Income: -$97.17M2019FY 2020 Revenue: $227.5MFY 2020 Net Income: -$143.6M2020FY 2021 Revenue: $78.45MFY 2021 Net Income: -$269.1M2021FY 2022 Revenue: $75.47MFY 2022 Net Income: -$233.7M2022FY 2023 Revenue: $116.3MFY 2023 Net Income: -$209.2M2023FY 2024 Revenue: $332.3MFY 2024 Net Income: -$51.74M2024FY 2025 Revenue: $403.1MFY 2025 Net Income: -$22.68M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $403.1M $332.3M $116.3M $75.47M $78.45M $227.5M $148.4M $0 -- --
Research & Development $47.85M $46.24M $86.11M $118.9M $106.0M $146.9M $175.6M $171.5M $147.6M $57.87M
Selling, General & Admin $165.8M $163.1M $142.5M $109.1M $185.0M $199.6M $65.85M $33.10M -- --
Total Operating Expenses $342.9M $277.9M $271.9M $255.0M $305.2M $348.9M $241.5M $204.6M $169.0M $76.15M
Operating Income $60.27M $54.40M -$155.6M -$179.5M -$226.7M -$121.4M -$93.10M -$204.6M -$169.0M -$76.15M
EBITDA $60.38M $54.47M -$155.4M -$179.0M -$226.1M -$120.8M -$92.78M -$204.3M -$168.7M -$75.90M
Interest Expense $84.60M $59.25M $58.98M $56.81M $46.35M $22.67M $8.12M $28K $198K $376K
Income Before Tax -$20.84M -$51.74M -$209.2M -- -- -- -- -- -- --
Income Tax Expense $1.84M $0 $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$22.68M -$51.74M -$209.2M -$233.7M -$269.1M -$143.6M -$97.17M -$201.8M -$167.0M -$74.98M
Basic EPS -$0.11 -$0.28 -$2.03 -$3.52 -$9.31 -$5.23 -$3.59 -$7.54 -$6.98 -$3.33
Diluted EPS -$0.11 -$0.28 -$2.03 -$3.52 -$9.31 -$5.23 -$3.59 -$7.54 -$6.98 -$3.33
Basic Shares Outstanding 207.9M 187.2M 103.1M 66.4M 28.9M 27.5M 27.1M 26.8M 23.9M 22.5M
Diluted Shares Outstanding 207.9M 187.2M 103.1M 66.4M 28.9M 27.5M 27.1M 26.8M 23.9M 22.5M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Revenue $80.10M $168.4M $87.31M $82.39M $65.00M $69.11M $51.63M $73.83M
Research & Development $8.99M $13.93M $14.13M $7.24M $12.56M $10.98M $10.40M $11.46M
Selling, General & Admin $43.12M $41.43M $41.85M $39.51M $43.00M $36.92M $39.98M $44.19M
Total Operating Expenses $86.69M $83.21M $97.27M $75.29M $87.09M $73.53M $67.66M $71.25M
Operating Income -$6.58M $85.23M -$9.96M $7.09M -$22.10M -$4.42M -$16.03M $2.58M
EBITDA -$6.55M $85.26M -$9.93M $7.12M -$22.07M -$4.39M -$16.00M $2.59M
Interest Expense $19.80M $22.64M $22.05M $20.49M $19.43M $16.42M $15.08M $13.72M
Income Tax Expense $0 $1.84M $0 $0 $0 $0 $0 $0
Net Income -$25.20M $61.83M -$31.33M -$12.72M -$40.45M -$21.32M -$29.52M -$61.92M
Basic EPS -$0.10 -- -$0.16 -$0.06 -$0.21 -- -$0.15 -$0.33
Diluted EPS -$0.10 -- -$0.16 -$0.06 -$0.21 -- -$0.15 -$0.33
Basic Shares Outstanding 251.4M -- 200.7M 197.5M 196.1M -- 194.9M 188.8M
Diluted Shares Outstanding 251.4M -- 200.7M 197.5M 196.1M -- 194.9M 188.8M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $167.9M $144.8M $82.25M $124.8M $208.9M $305.0M $166.1M $36.97M $34.47M $38.16M
Short-Term Investments -- -- $0 $42.09M $50.44M $0 $34.65M $99.05M $165.7M --
Cash & Short-Term Investments $167.9M $144.8M $82.25M $166.9M $259.3M $305.0M $200.8M $136.0M $200.2M $38.16M
Accounts Receivable, Net $140.2M $80.14M $48.49M $33.73M $22.93M $12.39M -- -- -- --
Inventory $105.1M $94.49M $65.62M $35.20M $34.39M $16.14M $0 -- -- --
Total Current Assets $462.6M $338.0M $201.1M $246.7M $329.0M $345.9M $211.7M $142.6M $203.9M $213.6M
Property, Plant & Equipment, Net $338K $254K $0 $164K $664K $1.28M $1.15M $520K $435K $674K
Intangible Assets -- -- -- $56K $56K $56K -- -- -- --
Long-Term Investments -- -- -- -- -- -- -- $243K $73.42M --
Other Non-Current Assets -- -- -- -- -- -- $56K -- -- --
Total Non-Current Assets $3.32M $5.82M $4.73M $1.26M $52.62M $7.36M $2.73M $819K $73.91M $31.64M
Total Assets $465.9M $343.8M $205.8M $247.9M $381.6M $353.3M $214.4M $143.5M $277.8M $245.2M
Accounts Payable $65.07M $51.65M $31.72M $23.04M $17.56M $51.98M $28.86M $44.89M $20.38M $4.59M
Short-Term Debt -- -- -- -- -- -- -- -- $1.04M $1.71M
Deferred Revenue (Current) $34.48M $8.52M $25.40M $3.51M $5.68M $1.66M $2.15M -- -- --
Other Current Liabilities -- -- $990K $279K $167K $52K $211K $296K $48K $143K
Total Current Liabilities $300.8M $246.2M $156.2M $92.31M $73.35M $94.07M $66.08M $64.33M $33.14M $15.59M
Long-Term Debt -- -- -- -- -- -- -- -- -- $1.02M
Deferred Revenue (Non-Current) -- -- -- $0 $634K $0 -- -- -- --
Other Non-Current Liabilities $8.74M $0 -- -- $0 $1.29M $0 -- -- --
Total Non-Current Liabilities $467.0M $486.3M $504.6M $479.4M $505.2M $355.3M $128.4M $0 $0 $1.02M
Total Liabilities $767.9M $732.5M $660.8M $571.7M $578.5M $449.4M $194.5M $64.33M $33.14M $16.61M
Total Debt (incl. Leases) $2.75M $5.31M $4.57M $1.05M $1.92M $6.04M $1.56M -- $1.04M $2.73M
Common Stock $245K $196K $118K $75K $61K $26K $27K $27K $26K $23K
Retained Earnings -$1.62B -$1.60B -$1.55B -$1.34B -$1.11B -$838.8M -$695.3M -$598.1M -$396.3M -$229.2M
Accumulated Other Comp. Income $0 $0 $0 -$2.0K -$31K $0 $23K -$319K -$845K -$172K
Total Stockholders' Equity -$302.0M -$388.7M -$455.0M -$323.8M -$196.9M -$96.13M $19.95M $79.12M $244.7M $228.6M
Total Equity -$302.0M -$388.7M -$455.0M -$323.8M -$196.9M -$96.13M $19.95M $79.12M $244.7M $228.6M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Cash & Cash Equivalents $156.2M $167.9M $92.45M $86.06M $114.6M $144.8M $144.7M $189.3M
Cash & Short-Term Investments $156.2M $167.9M $92.45M $86.06M $114.6M $144.8M $144.7M $189.3M
Accounts Receivable, Net $132.4M $140.2M $119.0M $107.7M $81.29M $80.14M $67.82M $60.36M
Inventory $104.2M $105.1M $108.5M $114.5M $99.32M $94.49M $80.10M $84.47M
Total Current Assets $459.5M $462.6M $360.5M $342.6M $318.8M $338.0M $307.6M $345.1M
Property, Plant & Equipment, Net $311K $338K $175K $201K $228K $254K $281K $307K
Total Non-Current Assets $3.07M $3.32M $3.56M $4.49M $5.25M $5.82M $6.56M $7.21M
Total Assets $462.5M $465.9M $364.0M $347.1M $324.0M $343.8M $314.1M $352.3M
Accounts Payable $68.41M $65.07M $77.51M $74.70M $71.99M $51.65M $34.86M $47.67M
Deferred Revenue (Current) $43.53M $34.48M $30.68M $22.31M $4.54M $8.52M $15.08M $20.67M
Total Current Liabilities $300.4M $300.8M $359.0M $298.8M $271.0M $246.2M $165.9M $175.3M
Other Non-Current Liabilities $8.74M $8.74M $7.44M $7.44M -- $0 -- --
Total Non-Current Liabilities $470.1M $467.0M $456.3M $481.8M $479.3M $486.3M $518.5M $521.2M
Total Liabilities $770.5M $767.9M $815.4M $780.6M $750.2M $732.5M $684.3M $696.5M
Total Debt (incl. Leases) $2.56M $2.75M $3.15M $4.05M $4.79M $5.31M $6.04M $6.66M
Common Stock $257K $245K $205K $200K $197K $196K $195K $195K
Retained Earnings -$1.65B -$1.62B -$1.69B -$1.65B -$1.64B -$1.60B -$1.58B -$1.55B
Accumulated Other Comp. Income -- $0 -- -- -- $0 -- $0
Total Stockholders' Equity -$307.9M -$302.0M -$451.4M -$433.5M -$426.2M -$388.7M -$370.2M -$344.2M
Total Equity -$307.9M -$302.0M -$451.4M -$433.5M -$426.2M -$388.7M -$370.2M -$344.2M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$22.68M -$51.74M -$209.2M -$233.7M -$269.1M -$143.6M -$97.17M -$201.8M -$167.0M -$74.98M
Depreciation & Amortization $105K $63K $164K $500K $612K $547K $319K $265K $258K $252K
Stock-Based Compensation $9.87M $11.99M $11.96M $15.21M $24.31M $28.39M $25.88M $23.97M $18.61M $15.96M
Change in Receivables -$60.05M -$31.65M -$14.77M -$10.79M -$10.55M -$12.39M $0 -- -- --
Change in Inventory -$10.63M -$28.87M -$30.42M -$807K -$18.26M -$16.14M $0 $0 -- --
Change in Payables $20.92M $12.43M $8.68M $5.60M -$34.10M $23.11M -$16.05M $24.45M $15.76M $3.89M
Operating Cash Flow -$13.09M -$23.65M -$135.5M -$174.8M -$263.8M -$85.18M -$70.34M -$148.6M -$131.3M -$47.73M
Capital Expenditure $0 -$317K $0 $0 $0 -$869K -$953K -$151K -$19K -$94K
Free Cash Flow -$13.09M -$23.97M -$135.5M -$174.8M -$263.8M -$86.05M -$71.29M -$148.8M -$131.3M -$47.82M
Purchases of Investments -- $0 $0 -$59.90M -$50.48M -$4.42M -$34.33M -$25.48M -$219.6M -$197.2M
Investing Cash Flow $0 -$317K $42.50M $8.10M -$50.48M $21.36M $64.23M $140.4M -$35.85M $10.12M
Common Stock Issued -- $513K $4.45M $90.85M $9.71M $0 $0 -- $164.0M --
Share Repurchases -- -- -- -- $0 -$55.00M $0 $0 -- --
Financing Cash Flow $36.18M $86.48M $50.46M $32.61M $268.2M $201.7M $136.2M $10.69M $163.5M -$1.56M
Net Change in Cash $23.09M $62.51M -$42.53M -$134.1M -$46.07M $137.9M $130.1M $2.50M -$3.70M -$39.17M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Net Income -$25.20M $61.83M -$31.33M -$12.72M -$40.45M -$21.32M -$29.52M -$61.92M
Depreciation & Amortization $27K $26K $26K $27K $26K $27K $26K $10K
Stock-Based Compensation $2.50M $2.39M $2.35M $2.67M $2.46M $2.81M $3.02M $2.93M
Change in Receivables $7.84M -$21.21M -$11.23M -$26.45M -$1.15M -$12.32M -$7.46M -$5.75M
Change in Inventory $915K $3.42M $5.93M -$15.14M -$4.83M -$14.39M $4.37M -$11.37M
Change in Payables $3.34M -$12.45M $2.90M $2.62M $27.84M $9.30M -$12.77M $19.35M
Operating Cash Flow -$27.72M $45.24M -$4.29M -$31.42M -$22.63M -$34.95M -$35.33M -$7.21M
Capital Expenditure -$189K $0 $0 $0 $0 $0 -$167K -$77K
Free Cash Flow -$27.91M $45.24M -$4.29M -$31.42M -$22.63M -$34.95M -$35.49M -$7.28M
Investing Cash Flow -$189K $0 $0 $0 $0 $0 -$167K -$77K
Common Stock Issued -- -- $0 $0 $0 -$90.16M $0 $0
Financing Cash Flow $16.22M $30.16M $10.67M $2.85M -$7.50M $35.00M -$9.10M -$30.02M
Net Change in Cash -$11.69M $75.41M $6.39M -$28.57M -$30.13M $44K -$44.59M -$37.30M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin 15.0% 16.4% -133.7% -237.8% -289.0% -53.3% -62.8% -- -- --
Net Profit Margin -5.6% -15.6% -179.9% -309.6% -343.0% -63.1% -65.5% -- -- --
Return on Equity (ROE) -- -- -- -- -- -- -487.0% -255.1% -68.2% -32.8%
Return on Assets (ROA) -4.9% -15.0% -101.7% -94.2% -70.5% -40.6% -45.3% -140.7% -60.1% -30.6%
Current Ratio 1.54x 1.37x 1.29x 2.67x 4.48x 3.68x 3.20x 2.22x 6.15x 13.70x
Quick Ratio 1.19x 0.99x 0.87x 2.29x 4.02x 3.51x 3.20x 2.11x 6.04x 2.45x
Debt to Equity -- -- -- -- -- -- 0.08x -- 0.00x 0.01x
Revenue Growth (YoY) +21.3% +185.7% +54.1% -3.8% -65.5% +53.4% -- -- -- --
Operating Income Growth (YoY) +10.8% -- -- -- -- -- -- -- -- --
5Y Revenue / Share Growth -76.6% -67.6% -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Operating Margin 18.1% 15.0% -9.7% -13.2% -15.4% 16.4% 5.6% 1.8%
Net Profit Margin -1.8% -5.6% -34.8% -38.8% -59.0% -15.6% -29.4% -35.5%
Return on Assets (ROA) -1.6% -4.9% -29.1% -30.0% -47.3% -15.0% -27.6% -28.0%
Current Ratio 1.53x 1.54x 1.00x 1.15x 1.18x 1.37x 1.85x 1.97x
Quick Ratio 1.18x 1.19x 0.70x 0.76x 0.81x 0.99x 1.37x 1.49x
Revenue Growth (YoY) +23.2% +143.7% +69.1% +11.6% -52.8% +114.3% +52.0% +186.3%
Operating Income Growth (YoY) -- -- -- +175.1% -130.6% -- -- --
Net Income Growth (YoY) -- -- -- -- -166.3% -- -- --
EPS Growth (YoY) -- -- -- -- -158.3% -- -- --
Operating Cash Flow Growth (YoY) -- -- -- -- -142.0% -- -- --
Free Cash Flow Growth (YoY) -- -- -- -- -142.1% -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001434868) · from December 31, 2011 Data through March 31, 2026 · synced Nov 20, 2026, 05:34 UTC · Open in terminal